1. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

2. Program Goals

3. Peglispro* vs Glargine: Effects on HbA1c in Pooled Analysis of Data From IMAGINE Trials 1-5

4. Peglispro* vs Glargine: Hypoglycemia Rates in Pooled Analysis Data From IMAGINE Trials 1-5

5. IDegLira* vs Glargine Comparison of Efficacy and Safety in DUAL V

7. LixiLan* vs Glargine No Increased Risk of Hypoglycemia at Any HbA1c Reduction Level

8. Post Hoc Analysis of EDITION 1 and 2 Effects of U300 vs Glargine on HbA1c

10. Clinical Implications for New and Emerging Long-Acting Insulins Which Patients May Benefit?

11. Abbreviations

12. References

13. References (cont)

14. References (cont)

15. References (cont)

16. References (cont)

17. References (cont)

18. References (cont)